The impact of preadmission oral bisphosphonate use on 30-day mortality following stroke: a population-based cohort study of 100,043 patients

References

• SureshEPazianasMAbrahamsenBSafety issues with bisphosphonate therapy for osteoporosisRheumatology (Oxford)2014531193123838024
   PubMed Web of Science ®Google Scholar
• BlackDMDelmasPDEastellRHORIZON Pivotal Fracture TrialOnce-yearly zoledronic acid for treatment of postmenopausal osteoporosisN Engl J Med2007356181809182217476007
   PubMed Web of Science ®Google Scholar
• HowardPABarnesBJVacekJLChenWLaiSMImpact of bisphosphonates on the risk of atrial fibrillationAm J Cardiovasc Drugs201010635936721090829
   PubMed Web of Science ®Google Scholar
• SharmaAChatterjeeSArbab-ZadehARisk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysisChest201314441311132223722644
   PubMed Web of Science ®Google Scholar
• FrostLEngholmGJohnsenSMollerHHustedSIncident stroke after discharge from the hospital with a diagnosis of atrial fibrillationAm J Med20001081364011059439
   PubMed Web of Science ®Google Scholar
• AbrahamsenBEikenPBrixenKAtrial fibrillation in fracture patients treated with oral bisphosphonatesJ Intern Med2009265558159219141097
   PubMed Web of Science ®Google Scholar
• ChristensenSMehnertFChapurlatRDBaronJASorensenHTOral bisphosphonates and risk of ischemic stroke: a case-control studyOsteoporos Int20112261773177920945149
   PubMed Web of Science ®Google Scholar
• WilkinsonGSBaillargeonJKuoYFFreemanJLGoodwinJSAtrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancerJ Clin Oncol201028334898490520940190
   PubMed Web of Science ®Google Scholar
• LuPYHsiehCFTsaiYWHuangWFAlendronate and raloxifene use related to cardiovascular diseases: differentiation by different dosing regimens of alendronateClin Ther20113391173117921849210
   PubMed Web of Science ®Google Scholar
• KangJHKellerJJLinHCA population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of strokeOsteoporos Int201223102551255722270858
   PubMed Web of Science ®Google Scholar
• VestergaardPSchwartzKPinholtEMRejnmarkLMosekildeLStroke in relation to use of raloxifene and other drugs against osteoporosisOsteoporos Int20112241037104520449570
   PubMed Web of Science ®Google Scholar
• LokeYKJeevananthamVSinghSBisphosphonates and atrial fibrillation: systematic review and meta-analysisDrug Saf200932321922819338379
   PubMed Web of Science ®Google Scholar
• BlackDMReidIRBoonenSThe effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)J Bone Miner Res201227224325422161728
   PubMed Web of Science ®Google Scholar
• LylesKWColon-EmericCSMagazinerJSHORIZON Recurrent Fracture TrialZoledronic acid and clinical fractures and mortality after hip fractureN Engl J Med2007357181799180917878149
   PubMed Web of Science ®Google Scholar
• KaramRCammJMcClungMYearly zoledronic acid in postmenopausal osteoporosisN Engl J Med20073577712713 author reply 714–71517703529
   PubMed Web of Science ®Google Scholar
• MukherjeeDPatilCGEpidemiology and the global burden of strokeWorld Neurosurg2011766 SupplS85S9022182277
   PubMed Web of Science ®Google Scholar
• JohannesdottirSAHorvath-PuhoEEhrensteinVSchmidtMPedersenLSorensenHTExisting data sources for clinical epidemiology: the Danish national database of reimbursed prescriptionsClin Epidemiol2012430331323204870
   PubMedGoogle Scholar
• SchmidtMPedersenLSorensenHTThe Danish civil registration system as a tool in epidemiologyEur J Epidemiol201429854154924965263
   PubMed Web of Science ®Google Scholar
• LyngeESandegaardJLReboljMThe Danish national patient registerScand J Public Health2011397 Suppl303321775347
   PubMed Web of Science ®Google Scholar
• SchmidtMJacobsenJBJohnsenSPBotkerHESorensenHTEighteen-year trends in stroke mortality and the prognostic influence of comorbidityNeurology201482434035024363134
   PubMed Web of Science ®Google Scholar
• RayWAEvaluating medication effects outside of clinical trials: new-user designsAm J Epidemiol2003158991592014585769
   PubMed Web of Science ®Google Scholar
• AbrahamsenBvan StaaTArielyROlsonMCooperCExcess mortality following hip fracture: a systematic epidemiological reviewOsteoporos Int200920101633165019421703
   PubMed Web of Science ®Google Scholar
• SchmidtMHovath-PuhoEChristiansenCFPetersenKLBotkerHESorensenHTPreadmission use of nonaspirin nonsteroidal anti-inflammatory drugs and 30-day stroke mortalityNeurology201483222013202225378670
   PubMed Web of Science ®Google Scholar
• BrookhartMASchneeweissSRothmanKJGlynnRJAvornJSturmerTVariable selection for propensity score modelsAm J Epidemiol2006163121149115616624967
   PubMed Web of Science ®Google Scholar
• AustinPCPropensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvementJ Thorac Cardiovasc Surg200713451128113517976439
   PubMed Web of Science ®Google Scholar
• AndersenKKAndersenZJOlsenTSPredictors of early and late case-fatality in a nationwide Danish study of 26,818 patients with first-ever ischemic strokeStroke201142102806281221817152
   PubMed Web of Science ®Google Scholar
• SaposnikGHillMDO’DonnellMRegistry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working GroupVariables associated with 7-day, 30-day, and 1-year fatality after ischemic strokeStroke20083982318232418566303
   PubMed Web of Science ®Google Scholar
• van AschCJLuitseMJRinkelGJvan der TweelIAlgraAKlijnCJIncidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysisLancet Neurol20109216717620056489
   PubMed Web of Science ®Google Scholar
• LovelockCERinkelGJRothwellPMTime trends in outcome of subarachnoid hemorrhage: population-based study and systematic reviewNeurology201074191494150120375310
   PubMed Web of Science ®Google Scholar
• ThompsonKRoelofsAJJauhiainenMMonkkonenHMonkkonenJRogersMJActivation of gammadelta T cells by bisphosphonatesAdv Exp Med Biol2010658112019950011
   PubMed Web of Science ®Google Scholar
• YlitaloRBisphosphonates and atherosclerosisGen Pharmacol200035628729611922958
   PubMedGoogle Scholar
• AriyoshiTEishiKSakamotoIMatsukumaSOdateTEffect of etidronic acid on arterial calcification in dialysis patientsClin Drug Investig2006264215222
   Web of Science ®Google Scholar
• KawaharaTNishikawaMKawaharaCInazuTSakaiKSuzukiGAtorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trialCirculation2013127232327233523658438
   PubMed Web of Science ®Google Scholar
• KoshiyamaHNakamuraYTanakaSMinamikawaJDecrease in carotid intima-media thickness after 1-year therapy with etidronate for osteopenia associated with type 2 diabetesJ Clin Endocrinol Metab20008582793279610946883
   PubMed Web of Science ®Google Scholar
• NittaKAkibaTSuzukiKEffects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysisAm J Kidney Dis200444468068815384019
   PubMed Web of Science ®Google Scholar
• TankoLBQinGAlexandersenPBaggerYZChristiansenCEffective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic womenOsteoporos Int200516218419015197541
   PubMed Web of Science ®Google Scholar
• LakhanSEKirchgessnerAHoferMInflammatory mechanisms in ischemic stroke: therapeutic approachesJ Transl Med200979719919699
   PubMed Web of Science ®Google Scholar
• ChaudhryHZhouJZhongYRole of cytokines as a double-edged sword in sepsisIn Vivo201327666968424292568
   PubMed Web of Science ®Google Scholar
• AppelrosPNydevikISeigerATerentAPredictors of severe stroke: influence of preexisting dementia and cardiac disordersStroke200233102357236212364721
   PubMed Web of Science ®Google Scholar
• VerninoSBrownRDJrSejvarJJSicksJDPettyGWO’FallonWMCause-specific mortality after first cerebral infarction: a population-based studyStroke20033481828183212855836
   PubMed Web of Science ®Google Scholar
• PengYLHuHYLuoJCHouMCLinHCLeeFYAlendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based studyOsteoporos Int20142551617162324566586
   PubMed Web of Science ®Google Scholar
• DavenportRJDennisMSWarlowCPGastrointestinal hemorrhage after acute strokeStroke19962734214248610306
   PubMed Web of Science ®Google Scholar
• HsuHLLinYHHuangYCGastrointestinal hemorrhage after acute ischemic stroke and its risk factors in AsiansEur Neurol200962421221819622888
   PubMed Web of Science ®Google Scholar
• O’DonnellMJKapralMKFangJInvestigators of the Registry of the Canadian Stroke NetworkGastrointestinal bleeding after acute ischemic strokeNeurology200871965065518685137
   PubMed Web of Science ®Google Scholar
• CramerJAGoldDTSilvermanSLLewieckiEMA systematic review of persistence and compliance with bisphosphonates for osteoporosisOsteoporos Int20071881023103117308956
   PubMed Web of Science ®Google Scholar
• KrarupLHBoysenGJanjuaHPrescottETruelsenTValidity of stroke diagnoses in a national register of patientsNeuroepidemiology200728315015417478969
   PubMed Web of Science ®Google Scholar
• QuXHuangXJinFBone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studiesInt J Cardiol2013166238539322112679
   PubMed Web of Science ®Google Scholar
• WangLMansonJESessoHDCalcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trialsAm J Cardiovasc Drugs201212210511622283597
   PubMed Web of Science ®Google Scholar
• BodyJJBergmannPBoonenSExtraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medicationsOsteoporos Int201223Suppl 1S1S2322311111
   PubMed Web of Science ®Google Scholar
• BollandMJGreyAReidIRCalcium supplements and cardiovascular risk: 5 years onTher Adv Drug Saf20134519921025114781
   PubMedGoogle Scholar
• PooleKELoveridgeNBarkerPJReduced vitamin D in acute strokeStroke200637124324516322500
   PubMed Web of Science ®Google Scholar
• TuWJZhaoSJXuDJChenHSerum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic strokeClin Sci (Lond)2014126533934624020395
   PubMed Web of Science ®Google Scholar
• DaubailBJacquinAGuillandJCSerum 25-hydroxyvitamin D predicts severity and prognosis in stroke patientsEur J Neurol2013201576122632854
   PubMed Web of Science ®Google Scholar